文献速递妇科

Ⅰ期上皮性卵巢癌保留生育功能手术后的全因死亡率

All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
PubMed 文献 · Obstet Gynecol · 2017-01-01

基于美国国家癌症数据库的队列研究纳入2004至2012年诊断的40岁以下ⅠA期及单侧ⅠC期上皮性卵巢癌女性1726例,其中825例(47.8%)接受保留生育功能手术;倾向性评分匹配后904例,中位随访63个月,保留生育功能手术与常规手术的全因死亡风险无显著差异(HR 0.80,95%CI 0.49-1.29,P=.36)。

要点

  • 40岁以下ⅠA期及单侧ⅠC期上皮性卵巢癌女性中,保留生育功能手术与常规手术的全因死亡风险无显著差异。
  • 匹配队列中位随访63个月,保留生育功能手术组30例死亡,常规手术组37例死亡。
  • 诊断后10年生存概率保留生育功能手术组为88.5%,常规手术组为88.9%。

核心结论

  • 与传统手术相比,年轻Ⅰ期上皮性卵巢癌女性接受保留生育功能手术与死亡风险增加无关。

研究设计与样本

  • 使用美国国家癌症数据库的队列研究,纳入2004年至2012年诊断的40岁以下ⅠA期及单侧ⅠC期上皮性卵巢癌女性,保留生育功能手术定义为保留一侧卵巢和子宫。
  • 共识别1726例女性,其中825例(47.8%)接受保留生育功能手术;采用倾向性评分方法构建均衡队列904例,使用Kaplan-Meier法和Cox比例风险模型进行生存分析。

主要发现

  • 保留生育功能手术与较年轻年龄、居住于美国东北部和西部、浆液性或黏液性组织学相关(P均<.05)。
  • 中位随访63个月,保留生育功能手术组观察到30例死亡,倾向性匹配的常规手术组观察到37例死亡。
  • 保留生育功能手术与死亡风险无关(风险比0.80,95%置信区间0.49-1.29,P=.36)。
  • 诊断后10年生存概率在保留生育功能手术组为88.5%(95%置信区间82.4-92.6),在常规手术组为88.9%(95%置信区间84.9-92.0)。
  • 在高危特征(透明细胞组织学、3级或ⅠC期)患者中,保留生育功能手术组10年生存率为80.5%(95%置信区间68.5-88.3),常规手术组为83.4%(95%置信区间76.0-88.7),风险比0.86(95%置信区间0.49-1.53,P=.61)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare all-cause mortality between women who underwent fertility-sparing surgery with those who underwent conventional surgery for stage I ovarian cancer. METHODS: In a cohort study using the National Cancer Database, we identified women younger than 40 years diagnosed with stage IA and unilateral IC epithelial ovarian cancer between 2004 and 2012. Fertility-sparing surgery was defined as conservation of one ovary and the uterus. The primary outcome was time from diagnosis to death. We used propensity score methods to assemble a cohort of women who underwent fertility-sparing or conventional surgery but were otherwise similar on observed covariates and conducted survival analyses using the Kaplan-Meier method and Cox proportional hazard models. RESULTS: We identified 1,726 women with stage IA and unilateral IC epithelial ovarian cancer of whom 825 (47.8%) underwent fertility-sparing surgery. Fertility-sparing surgery was associated with younger age, residence in the northeastern and western United States, and serous or mucinous histology (P<.05 for all). Propensity score matching yielded a cohort of 904 women who were balanced on observed covariates. We observed 30 deaths among women who underwent fertility-sparing surgery and 37 deaths among propensity-matched women who underwent conventional surgery after a median follow-up of 63 months. Fertility-sparing surgery was not associated with hazard of death (hazard ratio 0.80, 95% confidence interval [CI] 0.49-1.29, P=.36). The probability of survival 10 years after diagnosis was 88.5% (95% CI 82.4-92.6) in the fertility-sparing group and 88.9% (95% CI 84.9-92.0) in the conventional surgery group. In patients with high-risk features such as clear cell histology, grade 3, or stage IC, 10-year survival was 80.5% (95% CI 68.5-88.3) among women who underwent fertility-sparing surgery and 83.4% (95% 76.0-88.7) among those who had conventional surgery (hazard ratio 0.86, 95% CI 0.49-1.53, P=.61). CONCLUSION: Compared with conventional surgery, fertility-sparing surgery was not associated with increased risk of death in young women with stage I epithelial ovarian cancer.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Melamed A, Rizzo AE, Nitecki R, et al. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Obstet Gynecol. 2017. PMID: 28594773. doi:10.1097/AOG.0000000000002102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。